Skip to main content
Erschienen in: Tumor Biology 5/2013

01.10.2013 | Research Article

Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis

verfasst von: Manzoor Ahmad Malik, Annapurna Gupta, Showkat Ali Zargar, Balraj Mittal

Erschienen in: Tumor Biology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Genetic alterations in the deleted in colorectal carcinoma (DCC) gene have been a priori reported to associate with metastasis in variety of human cancers. We investigated the association between potentially functional SNPs in DCC and susceptibility to esophageal (EC) and gastric (GC) cancers in Kashmir Valley. We genotyped two SNPs DCC rs714 (A>G) and DCC rs2229080 (C>G) of DCC in 135 EC patients, 108 GC patients, and 195 controls matched by age and sex in Kashmir Valley by polymerase chain reaction–RFLP method. Risk for developing EC and GC was estimated by binary logistic regression by using SPSS. We also performed a meta-analysis on DCC rs714 (A>G) and evaluated the association between the DCC rs714 (A>G) polymorphisms and cancer risk. A significant difference in DCC rs714 (A>G) genotype distribution between EC and GC cases and corresponding control groups was observed (odds ratio (OR) = 1.92; P = 0.03; P-trend = 0.04; false discovery rate (FDR) Pcorr = 0.03: OR = 2.15; P = 0.02; P-trend = 0.01; FDR Pcorr = 0.03). But no such association was observed in DCC rs2229080 (C>G). Further, DCC rs714 (A>G) AA genotype showed significantly increased risk for both gastric squamous cell carcinoma (OR = 5.63; P = 0.02; FDR Pcorr = 0.01) and gastric adenocarcinoma (OR = 2.15; P = 0.02; FDR Pcorr = 0.01). Smoking and salted tea are independently associated with both EC and GC, but gene–environment interaction did not further modulate the risk. Meta-analysis also suggested both independent and overall association of DCC rs714 (A>G) polymorphism with cancer (P = 0.000). In conclusion, genetic variations in DCC rs714 (A>G) modulate risk of EC and GC in high-risk Kashmir population.
Literatur
1.
Zurück zum Zitat Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594–606.CrossRefPubMed Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594–606.CrossRefPubMed
2.
Zurück zum Zitat Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13(2):102–11.CrossRefPubMed Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13(2):102–11.CrossRefPubMed
3.
Zurück zum Zitat Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33:11–5.PubMedCentralCrossRefPubMed Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33:11–5.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis. 1992;13:1331–5.CrossRefPubMed Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis. 1992;13:1331–5.CrossRefPubMed
5.
Zurück zum Zitat Siddiqiz M, Tricker AR, Preussmann R. The occurrence of preformed N nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir India. Cancer Lett. 1988;39:37–43.CrossRef Siddiqiz M, Tricker AR, Preussmann R. The occurrence of preformed N nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir India. Cancer Lett. 1988;39:37–43.CrossRef
6.
Zurück zum Zitat Malik MA, Zargar SA, Mittal B. Role of NQO1 609C>T and NQO2–3423G>A gene polymorphisms in esophageal cancer risk in Kashmir Valley and meta analysis. Mol Biol Rep. 2012;39(9):9095–104.CrossRefPubMed Malik MA, Zargar SA, Mittal B. Role of NQO1 609C>T and NQO2–3423G>A gene polymorphisms in esophageal cancer risk in Kashmir Valley and meta analysis. Mol Biol Rep. 2012;39(9):9095–104.CrossRefPubMed
7.
Zurück zum Zitat Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer. 2009;40:26–32.CrossRefPubMed Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer. 2009;40:26–32.CrossRefPubMed
8.
Zurück zum Zitat Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, et al. The DCC gene: structural analysis and mutations in colorectal carcinomas. Vogelstein B Genomics. 1994;19(3):525–31.CrossRefPubMed Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, et al. The DCC gene: structural analysis and mutations in colorectal carcinomas. Vogelstein B Genomics. 1994;19(3):525–31.CrossRefPubMed
9.
Zurück zum Zitat Krimpenfort P, Song JY, Proost N, Zevenhoven J, Jonkers J, Berns A. Deleted in Colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. Nature. 2012;482(7386):538–41. doi:10.1038/nature10790.CrossRefPubMed Krimpenfort P, Song JY, Proost N, Zevenhoven J, Jonkers J, Berns A. Deleted in Colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. Nature. 2012;482(7386):538–41. doi:10.​1038/​nature10790.CrossRefPubMed
10.
Zurück zum Zitat Maran S. Lee YY, Xu S, Rajab NS, Hasan N, Mustaffa N et al. Deleted in Colorectal Cancer (DCC) Gene Polymorphism is associated with H. pylori infection among susceptible Malays from the North-Eastern Region of Peninsular Malaysia. Hepatogastroenterology. 2012;Jul 25;60(121). doi: 10.5754/hge12471. Maran S. Lee YY, Xu S, Rajab NS, Hasan N, Mustaffa N et al. Deleted in Colorectal Cancer (DCC) Gene Polymorphism is associated with H. pylori infection among susceptible Malays from the North-Eastern Region of Peninsular Malaysia. Hepatogastroenterology. 2012;Jul 25;60(121). doi: 10.​5754/​hge12471.
11.
Zurück zum Zitat Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990;247:49–56.CrossRefPubMed Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990;247:49–56.CrossRefPubMed
12.
Zurück zum Zitat Fearon ER, Vogelste B. A genetic mode l for colorectal tumorigenesis. Cell. 1990;61:759–67.CrossRefPubMed Fearon ER, Vogelste B. A genetic mode l for colorectal tumorigenesis. Cell. 1990;61:759–67.CrossRefPubMed
13.
Zurück zum Zitat Itoh F, Hinoda Y, Ohe M, Ohe Y, Ban T, Endo T, et al. Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer. 1993;53:260–3.CrossRefPubMed Itoh F, Hinoda Y, Ohe M, Ohe Y, Ban T, Endo T, et al. Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer. 1993;53:260–3.CrossRefPubMed
14.
Zurück zum Zitat Reale MA, Hu G, Zafar AI, Getzenberg RH, Levine SM, Fearon ER. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res. 1994;54:4493–501.PubMed Reale MA, Hu G, Zafar AI, Getzenberg RH, Levine SM, Fearon ER. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res. 1994;54:4493–501.PubMed
15.
Zurück zum Zitat Fearon ER. DCC: is there a connection between tumorigenesis and cell guidance molecules? Biochim Biophys Acta. 1996;9(1288):M17–23. Fearon ER. DCC: is there a connection between tumorigenesis and cell guidance molecules? Biochim Biophys Acta. 1996;9(1288):M17–23.
16.
Zurück zum Zitat Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele Jr G, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med. 1996;335(23):1727–32.CrossRefPubMed Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele Jr G, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med. 1996;335(23):1727–32.CrossRefPubMed
17.
Zurück zum Zitat Sun XF, Rütten S, Zhang H, Nordenskjöld B. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. J Clin Oncol. 1999;17:1745–50.PubMed Sun XF, Rütten S, Zhang H, Nordenskjöld B. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. J Clin Oncol. 1999;17:1745–50.PubMed
18.
Zurück zum Zitat Toma M, Stavarachi M, Cimponeriu D, Apostol P, Cojocaru M, Belusica L et al. P53 And DCC Polymorphisms and the risk for colorectal cancer in Romanian patients—a preliminary study. Tom. XVI / 2, 2009, pp. 162–165. Toma M, Stavarachi M, Cimponeriu D, Apostol P, Cojocaru M, Belusica L et al. P53 And DCC Polymorphisms and the risk for colorectal cancer in Romanian patients—a preliminary study. Tom. XVI / 2, 2009, pp. 162–165.
19.
Zurück zum Zitat Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N, Nakamura YJ. A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. Hum Genet. 2012;57(4):235–7. doi:10.1038/jhg.2012.9.CrossRef Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N, Nakamura YJ. A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. Hum Genet. 2012;57(4):235–7. doi:10.​1038/​jhg.​2012.​9.CrossRef
20.
Zurück zum Zitat Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B. DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: GENE-D-12-01446). Gene. 2013;2013 Jan 23. Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B. DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: GENE-D-12-01446). Gene. 2013;2013 Jan 23.
21.
24.
Zurück zum Zitat Mattar R, Nonogaki S, Silva C, Alves V, Gama-Rodrigues JJ. P53 and Rb tumor suppressor gene alterations in gastric cancer. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(4):172–80.CrossRefPubMed Mattar R, Nonogaki S, Silva C, Alves V, Gama-Rodrigues JJ. P53 and Rb tumor suppressor gene alterations in gastric cancer. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(4):172–80.CrossRefPubMed
25.
Zurück zum Zitat Schmitt CA, Thaler KR, Wittig BM, Kaulen H, Büschenfelde CKMZ, Dippold WG. Detection of the DCC gene product in normal and malignant colorectal tissues and its related to a codon 201 mutation. Br J Cancer. 1998;77:588–94.PubMedCentralCrossRefPubMed Schmitt CA, Thaler KR, Wittig BM, Kaulen H, Büschenfelde CKMZ, Dippold WG. Detection of the DCC gene product in normal and malignant colorectal tissues and its related to a codon 201 mutation. Br J Cancer. 1998;77:588–94.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992;52:3099–102.PubMed Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992;52:3099–102.PubMed
27.
Zurück zum Zitat Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res. 1992;52(23):6525–30.PubMed Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res. 1992;52(23):6525–30.PubMed
28.
Zurück zum Zitat Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene. 1991;6(2):311–5.PubMed Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene. 1991;6(2):311–5.PubMed
29.
Zurück zum Zitat Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993;53(12):2723–7.PubMed Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993;53(12):2723–7.PubMed
30.
Zurück zum Zitat Höhne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992;52(9):2616–9.PubMed Höhne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992;52(9):2616–9.PubMed
31.
Zurück zum Zitat Scheck AC, Coons SW. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res. 1993;53:5605–9.PubMed Scheck AC, Coons SW. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res. 1993;53:5605–9.PubMed
32.
33.
Zurück zum Zitat Cho JH, Noguchi M, Ochiai A, Hirohashi S. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest. 1996;74:835–41.PubMed Cho JH, Noguchi M, Ochiai A, Hirohashi S. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest. 1996;74:835–41.PubMed
34.
Zurück zum Zitat Candusso ME, Luinetti O, Villani L, Alberizzi P, Klersy C, Fiocca R, et al. Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol. 2002;197:44–50.CrossRefPubMed Candusso ME, Luinetti O, Villani L, Alberizzi P, Klersy C, Fiocca R, et al. Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol. 2002;197:44–50.CrossRefPubMed
35.
Zurück zum Zitat Yoshiya G, Takahata T, Hanada N, Suzuki K, Ishiguro A, Saito M, et al. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol. 2008;23:948–53.CrossRefPubMed Yoshiya G, Takahata T, Hanada N, Suzuki K, Ishiguro A, Saito M, et al. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol. 2008;23:948–53.CrossRefPubMed
36.
Zurück zum Zitat Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature. 2004;431:80–4.CrossRefPubMed Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature. 2004;431:80–4.CrossRefPubMed
Metadaten
Titel
Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis
verfasst von
Manzoor Ahmad Malik
Annapurna Gupta
Showkat Ali Zargar
Balraj Mittal
Publikationsdatum
01.10.2013
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 5/2013
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0870-4

Weitere Artikel der Ausgabe 5/2013

Tumor Biology 5/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.